Over the past six years, the U.S. Supreme Court has issued a series of decisions—Bilski (link is external), Mayo (link is external), Myriad (link is external), and Alice (link is external)—that have significantly impacted patent eligibility law and continue to generate substantial public debate. We are seeking input from the public on patent subject-matter eligibility through two roundtables held Nov. 14 in Alexandria, Virginia, and Dec. 5 in Stanford, California.
This second roundtable will focus on receiving feedback regarding larger questions concerning the legal contours of eligible subject matter in the U.S. patent system. Additional details about the roundtables are in a Federal Register Notice (link is external) published Oct. 17, 2016.
Registration is free, on a first-come, first-served basis. Registrants may attend the roundtable in person in Stanford, California, or participate at the USPTO in Alexandria, VA. Register to attend Roundtable 2 (link is external).
Requests to speak: Those wishing to speak at the roundtable must submit an online registration no later than Nov. 14, 2016. Please indicate in the registration your interest in speaking at the event. Register to speak at Roundtable 2 (link is external).
Register to Attend and/or Register to Speak (link is external)
Written comments for Roundtable 2 will be accepted until Jan. 18, 2017. All comments should be sent to 101Roundtable2@uspto.gov (link sends e-mail).
Webcast: The roundtable will be available for viewing via live webcast.
Agenda: RT2 Agenda
35 U.S.C. § 101 defines inventions eligible for patenting as “any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof.” These classes of patent eligible subject matter have been narrowed by court opinions, which state that laws of nature, natural phenomena, and abstract ideas are not eligible for patenting.For non-press inquiries, please contact Elizabeth Shaw 571-272-9300, or e-mail firstname.lastname@example.org (link sends e-mail).
The following comments have been submitted in response to Federal Register Notice (link is external), published in the Federal Register at 81 Fed. Reg. 71485 (October 17, 2016).
Please note that the following documents are posted as originally received but may contain artifacts of scanning, OCR, and document format conversion for presentation on the USPTO.gov website.
A. Intellectual Property Organizations and other Associations
B. Government Agencies
C. Academic and Research Institutions
- Banbury Statement - Patenting Genes, Natural Products and Diagnostics: Current Status and Future Prospects
D. Law Firms